Page last updated: 2024-09-05

sorafenib and propidium

sorafenib has been researched along with propidium in 3 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(propidium)
Trials
(propidium)
Recent Studies (post-2010) (propidium)
6,5207305,2512,87710934

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)propidium (IC50)
CholinesteraseHomo sapiens (human)6.289
AcetylcholinesteraseHomo sapiens (human)6.289
Acetylcholinesterase Bos taurus (cattle)6.289

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BrĂ¼ning, A; Burger, P; Burges, A; Friese, K; Gingelmaier, A; Vogel, M1
Chen, D; Eyupoglu, IY; Savaskan, N1
Arafa, EA; Chen, PS; Hung, JH; Jeng, J; Omar, HA; Pan, HW; Wu, WD1

Other Studies

3 other study(ies) available for sorafenib and propidium

ArticleYear
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib.
    Investigational new drugs, 2010, Volume: 28, Issue:5

    Topics: Annexin A5; Antineoplastic Agents; Benzenesulfonates; Cell Death; Cell Line, Tumor; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; HIV Protease Inhibitors; Humans; Membrane Potential, Mitochondrial; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Nelfinavir; Niacinamide; Ovarian Neoplasms; Phenylurea Compounds; Phosphorylation; Propidium; Protein Stability; Proto-Oncogene Proteins c-bcl-2; Pyridines; Sorafenib

2010
Ferroptosis and Cell Death Analysis by Flow Cytometry.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1601

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dactinomycin; Flow Cytometry; Humans; Indicators and Reagents; Iron; Necrosis; Niacinamide; Phenylurea Compounds; Piperazines; Propidium; Rats; Sorafenib

2017
Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma.
    Scientific reports, 2018, 08-27, Volume: 8, Issue:1

    Topics: Animals; Annexin A5; Antrodia; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Hep G2 Cells; Humans; Immunoblotting; Liver Neoplasms; Mice; Mice, Inbred BALB C; Plant Extracts; Propidium; Sorafenib; Wound Healing

2018